Newsroom
Albemarle Supports the Future of GLP-1 Therapies
GLP-1 therapies, once for diabetes, are now transforming obesity care. As demand surges, pharmaceutical companies must scale fast — with precision partners like Albemarle ensuring consistent, reliable production.
ProductsOctober 22, 2025What’s the Difference Between Lithium Hydroxide and Lithium Carbonate?They may look like ordinary white powders, but lithium carbonate and lithium hydroxide have extraordinary roles. These compounds form the backbone of modern energy storage that powers everything from everyday electronics to advanced grid systems.
PeopleSeptember 19, 2025Ignacio Toro: Guiding Responsible Growth in ChileIgnacio Toro, Albemarle’s environmental manager in Chile, believes nature and development can coexist. His career — spanning government, nonprofits, and industry — focuses on sustainable, inclusive projects. At Albemarle, he leads a lithium extraction initiative using innovative, eco-friendly
PeopleAugust 13, 2025Jenny Nacu's Journey to Becoming a Lithium Leader and MentorJenny Nacu, a chemical engineer at Albemarle’s Kings Mountain facility, leads lithium hydroxide production with a focus on safety and performance. She mentors young engineers, encouraging growth through collaboration and resilience.
Albemarle Kings MountainAugust 06, 2025Cleveland County Commissioners Recognize Albemarle's Commitment to Public SafetyA formal proclamation recognized Albemarle's contributions to help local emergency responders.
Press ReleasesOctober 27, 2025Albemarle Announces Quarterly Common Stock DividendCHARLOTTE, N.C. , Oct. 27, 2025 -- The Board of Directors of Albemarle Corp. (NYSE: ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable January 2, 2026, to shareholders of record at the close of- Press ReleasesOctober 27, 2025Albemarle Announces Sale of a Controlling Stake in Ketjen to KPS Capital PartnersAlbemarle Separately Signs Agreement to Sell its 50% Stake in Eurecat Joint Venture to Axens SA Combined transactions strengthen Albemarle's financial flexibility and drive greater portfolio focus Albemarle expects to receive total pre-tax cash proceeds of approximately $660 million for the sale of
- Press ReleasesSeptember 25, 2025Albemarle Corporation to Release Third Quarter 2025 Earnings Results on Wednesday, November 5, 2025CHARLOTTE, N.C., Sept. 25, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its third quarter 2025 earnings after the NYSE closes on Wednesday, November 5, 2025
- Press ReleasesAugust 11, 2025Albemarle Announces Enhanced Organizational StructureAligns the company's functional model for greater agility and efficiency and is designed to accelerate market-led growth and operational excellence CHARLOTTE, N.C., Aug. 11, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy
From Resources - Mine and Brine - To Market
Download our media fact sheet to learn the role Albemarle plays in the extraction, conversion and processing of lithium and bromine.
Press & Media Contact
For press & media inquiries, please contact our Media Relations team - for all other inquiries please go through the Contact Us page.